Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Medicinal Chemistry|February 23, 2016
Repositioning Antitubercular 6-Nitro-2,3-dihydroimidazo[2,1-b][1,3]oxazoles for Neglected Tropical Diseases: Structure-Activity Studies on a Preclinical Candidate for Visceral LeishmaniasisAndrew M Thompson, Patrick D O'Connor, Adrian Blaser, et al.
Bioorganic & Medicinal Chemistry Letters|May 3, 2017
6-Nitro-2,3-dihydroimidazo[2,1-b][1,3]thiazoles: Facile synthesis and comparative appraisal against tuberculosis and neglected tropical diseasesAndrew M Thompson, Adrian Blaser, Brian D Palmer, et al.
European Journal of Medicinal Chemistry|August 31, 2015
Aminothiazoles: Hit to lead development to identify antileishmanial agentsDebnath Bhuniya, Rao Mukkavilli, Rahul Shivahare, et al.
European Journal of Medicinal Chemistry|December 3, 2020
Heteroaryl ether analogues of an antileishmanial 7-substituted 2-nitroimidazooxazine lead afford attenuated hERG risk: In vitro and in vivo appraisalAndrew M Thompson, Patrick D O'Connor, Andrew J Marshall, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 28, 2014
In vitro metabolism, disposition, preclinical pharmacokinetics and prediction of human pharmacokinetics of DNDI-VL-2098, a potential oral treatment for Visceral LeishmaniasisRao Mukkavilli, Jakir Pinjari, Bhavesh Patel, et al.
Journal of Medicinal Chemistry|February 21, 2018
Development of (6 R)-2-Nitro-6-[4-(trifluoromethoxy)phenoxy]-6,7-dihydro-5 H-imidazo[2,1- b][1,3]oxazine (DNDI-8219): A New Lead for Visceral LeishmaniasisAndrew M Thompson, Patrick D O'Connor, Andrew J Marshall, et al.
Journal of Medicinal Chemistry|May 2, 2017
7-Substituted 2-Nitro-5,6-dihydroimidazo[2,1-b][1,3]oxazines: Novel Antitubercular Agents Lead to a New Preclinical Candidate for Visceral LeishmaniasisAndrew M Thompson, Patrick D O'Connor, Andrew J Marshall, et al.
European Journal of Medicinal Chemistry|October 8, 2013
Design, synthesis and biological evaluation of 2-substituted quinolines as potential antileishmanial agentsVadiraj S Gopinath, Jakir Pinjari, Ravindra T Dere, et al.
Pageof 2